全球脑癌诊断市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

全球脑癌诊断市场需求预计将从 2022 年的 25 亿美元增至 2030 年的近 42.6 亿美元，2023-2030 年研究期间CAGR为 6.9%。

脑癌诊断涉及透过各种医疗程序、测试和影像技术来识别、评估和确定脑肿瘤或癌症。这些诊断对于准确诊断脑肿瘤、确定其特征、位置和大小以及对癌症严重程度进行分级至关重要。

市场动态：

脑癌诊断市场的成长受到技术进步、疾病发生率上升和医疗保健意识等多种因素的推动。成像技术的进步推动了对更精确和早期检测能力的需求。全球脑肿瘤盛行率的不断上升增加了对准确诊断工具和程序的需求，以促进早期发现和及时介入。提高认识活动和筛检措施进一步推动了高风险族群对诊断测试的需求。活检技术和基因检测的技术创新有助于更精确地表征肿瘤，有助于个人化治疗方法。此外，对非侵入性诊断方法的偏好促进了侵入性较小的技术的发展。政府支持、研究资助以及诊断公司和医疗机构之间的合作促进了先进脑癌诊断解决方案的创新和发展。总的来说，这些因素推动了脑癌诊断市场的成长，促进创建更有效、患者友善的诊断工具，用于早期检测和客製化治疗策略。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球脑癌诊断市场的每个细分市场进行了包容性评估。脑癌诊断产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲脑癌诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。脑癌诊断市场的主要参与者包括 GE Healthcare、Siemens Healthineers、Philips Healthcare、Thermo Fisher Scientific、Rare Diagnostics、Abbott Laboratories、Illumina Inc、Hologic Inc、Agilent Technologies、Bio Rad Laboratories。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：脑癌诊断 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 透过诊断技术进行市场吸引力分析
  • 按脑癌类型分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球脑癌诊断市场分析：按诊断技术

• 诊断技术概述
• 历史和预测数据
• 诊断技术分析
• 影像技术（磁振造影 (MRI)、电脑断层扫描 (C1) 扫描、PET 扫描或 PE CT 扫描、单光子发射电脑断层扫描 (SPECT) Scat）
• 组织取样/活检
• 分子诊断
• 其他的

第 6 章：全球脑癌诊断市场分析：按脑癌类型

• 脑癌类型概述
• 历史和预测数据
• 依脑癌类型分析
• 神经胶质瘤
• 脑膜瘤
• 脑下垂体肿瘤
• 其他的

第 7 章：全球脑癌诊断市场分析：依最终用户分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 医院
• 诊断实验室
• 癌症医院/中心

第 8 章：全球脑癌诊断市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：脑癌诊断公司的竞争格局

• 脑癌诊断市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• GE Healthcare
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Siemens Healthineers
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Philips Healthcare
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Thermo Fisher Scientific
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Rare Diagnostics
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Abbott Laboratories
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Illumina Inc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Hologic Inc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Agilent Technologies
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio Rad Laboratories
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Brain Cancer Diagnostics Market is presumed to reach the market size of nearly USD 4.26 BN by 2030 from USD 2.5 BN in 2022 with a CAGR of 6.9% under the study period 2023 - 2030.

Brain cancer diagnostics involve the identification, assessment, and determination of brain tumors or cancers through various medical procedures, tests, and imaging techniques. These diagnostics are crucial in accurately diagnosing brain tumors, determining their characteristics, location, and size, and grading the cancer's severity.

MARKET DYNAMICS:

The brain cancer diagnostics market experiences growth propelled by diverse factors at the intersection of technological advancements, rising disease incidence, and healthcare awareness. Advancements in imaging technologies drive the demand for more precise and early detection capabilities. The increasing prevalence of brain tumors worldwide amplifies the need for accurate diagnostic tools and procedures to facilitate early detection and timely intervention. Heightened awareness campaigns and screening initiatives further drive the demand for diagnostic tests among at-risk populations. Technological innovations in biopsy techniques and genetic testing contribute to more precise tumor characterization, aiding in personalized treatment approaches. Moreover, the preference for non-invasive diagnostic methods fosters the development of less invasive techniques. Government support, research funding, and collaborations between diagnostic firms and healthcare institutions foster innovation and the development of advanced brain cancer diagnostic solutions. Collectively, these factors fuel the growth of the brain cancer diagnostics market, promoting the creation of more effective, patient-friendly diagnostic tools for early detection and tailored treatment strategies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of brain cancer diagnostics. The growth and trends of brain cancer diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the brain cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Technique

• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat)
• Tissue Sampling/Biopsy
• Molecular Diagnostics
• Others

By Brain Cancer Type

• Gliomas
• Meningiomas
• Pituitary Tumors
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Cancer Hospitals/Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Brain Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brain Cancer Diagnostics market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Rare Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, Bio Rad Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . BRAIN CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Diagnostic Technique
  • 3.7.2 Market Attractiveness Analysis By Brain Cancer Type
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TECHNIQUE

• 5.1 Overview by Diagnostic Technique
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Diagnostic Technique
• 5.4 Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Historic and Forecast Sales by Regions
• 5.5 Tissue Sampling/Biopsy Historic and Forecast Sales by Regions
• 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
• 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY BRAIN CANCER TYPE

• 6.1 Overview by Brain Cancer Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Brain Cancer Type
• 6.4 Gliomas Historic and Forecast Sales by Regions
• 6.5 Meningiomas Historic and Forecast Sales by Regions
• 6.6 Pituitary Tumors Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
• 7.6 Cancer Hospitals/Centers Historic and Forecast Sales by Regions

8 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRAIN CANCER DIAGNOSTICS COMPANIES

• 9.1. Brain Cancer Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF BRAIN CANCER DIAGNOSTICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. GE Healthcare
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Siemens Healthineers
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Philips Healthcare
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Thermo Fisher Scientific
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Rare Diagnostics
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Abbott Laboratories
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Illumina Inc
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Hologic Inc
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Agilent Technologies
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Bio Rad Laboratories
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Diagnostic Technique (USD MN)
• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
• Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
• Molecular Diagnostics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Brain Cancer Type (USD MN)
• Gliomas Market Sales by Geography (USD MN)
• Meningiomas Market Sales by Geography (USD MN)
• Pituitary Tumors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Diagnostic Laboratories Market Sales by Geography (USD MN)
• Cancer Hospitals/Centers Market Sales by Geography (USD MN)
• Global Brain Cancer Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Brain Cancer Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Brain Cancer Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Diagnostic Technique
• Market Attractiveness Analysis by Brain Cancer Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Diagnostic Technique (USD MN)
• Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
• Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
• Molecular Diagnostics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Brain Cancer Type (USD MN)
• Gliomas Market Sales by Geography (USD MN)
• Meningiomas Market Sales by Geography (USD MN)
• Pituitary Tumors Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Diagnostic Laboratories Market Sales by Geography (USD MN)
• Cancer Hospitals/Centers Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.